Zurcher Kantonalbank »

Aquestive Therapeutics shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2025-12-31 $420k 65k 6.46

More positions owned by Zurcher Kantonalbank

Nvidia Corporation Note 2.500% 4/ (NVDA)
Apple Cl A (AAPL)
Microsoft Corporation (MSFT)
Ubs Group Call (UBS)
Amazon Put (AMZN)
Alphabet Call (GOOGL)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Shs New (GOOG)
Meta Platforms Call (META)
Jpmorgan Chase & Co. Call (JPM)
Eli Lilly & Co Call (LLY)
Alcon SHS (ALC)
Amrize Put (AMRZ)
Visa Com Cl A (V)

View all positions for Zurcher Kantonalbank

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
State Street Corporation
Geode Capital Management
Federated Investors
Sio Capital Management
Millennium Management
Susquehanna International
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Aquestive Therapeutics